Balancing Risk and Efficiency in Drug Development for Rare and Challenging Tumors: A New Paradigm for Glioma Innovations in molecular biology and immunology have revealed that distinct cancer ...

Increasingly, researchers are playing matchmaker between patients with metastatic cancer and targeted drugs via studies called basket trials. Drew Huggins was running out of options. After his ...

Dramatic responses observed with targeted agents in the ‘right’ genomic context have fueled large scale sequencing efforts to identify ‘effective’ treatments for a given patient. In order to ...